Dr. Timothy E. Byun
Claim this profileSaint Joseph Hospital - Orange
Studies Lung Cancer
Studies Breast cancer
30 reported clinical trials
84 drugs studied
About Timothy E. Byun
Education:
- Earned his MD from the University of California, Irvine School of Medicine.
- Completed residency in Internal Medicine at the University of California, Irvine Medical Center.
- Undertook a fellowship in Hematology and Oncology at the City of Hope National Medical Center.
Experience:
- Specializes in Hematology and Oncology at Saint Joseph Hospital - Orange.
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Timothy E. Byun is currently running
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Timothy E. Byun
Clinical Trial Related8 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Timothy E. Byun has experience with
- Pembrolizumab
- Oxaliplatin
- Paclitaxel
- Fluorouracil
- Nivolumab
- Ipatasertib
Breakdown of trials Timothy E. Byun has run
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy E. Byun specialize in?
Timothy E. Byun focuses on Lung Cancer and Breast cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Timothy E. Byun currently recruiting for clinical trials?
Yes, Timothy E. Byun is currently recruiting for 13 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Timothy E. Byun has studied deeply?
Yes, Timothy E. Byun has studied treatments such as Pembrolizumab, Oxaliplatin, Paclitaxel.
What is the best way to schedule an appointment with Timothy E. Byun?
Apply for one of the trials that Timothy E. Byun is conducting.
What is the office address of Timothy E. Byun?
The office of Timothy E. Byun is located at: Saint Joseph Hospital - Orange, Orange, California 92868 United States. This is the address for their practice at the Saint Joseph Hospital - Orange.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.